- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x PER: PEROXIDE ION(Non-covalent)
- 5 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
PGV.7: 34 residues within 4Å:- Chain A: F.94, P.95, R.96, M.97, M.100, F.148, H.151, L.152, I.158, L.159, P.200
- Chain C: H.9, V.11, G.20, A.24, T.28, L.31, N.50, T.53, M.54, W.57, W.58, V.61, E.64, H.71, L.79, G.82, F.86, S.89, E.90, F.93
- Ligands: PGV.38, PEK.44, DMU.54
20 PLIP interactions:11 interactions with chain C, 9 interactions with chain A- Hydrophobic interactions: C:A.24, C:T.28, C:L.31, C:T.53, C:W.57, C:W.57, C:W.57, C:W.58, C:F.86, C:F.93, A:F.148, A:L.152, A:I.158, A:L.159, A:P.200
- Hydrogen bonds: C:W.57, A:R.96, A:R.96, A:M.97
- Salt bridges: A:R.96
PGV.8: 18 residues within 4Å:- Chain A: N.406, T.408, W.409, I.412, R.480
- Chain D: T.80, A.84, F.87
- Chain K: F.9, H.10
- Chain M: A.3, K.4, P.5, P.12, Q.15, A.16, L.19, S.20
19 PLIP interactions:5 interactions with chain K, 5 interactions with chain D, 4 interactions with chain A, 5 interactions with chain M- Hydrophobic interactions: K:F.9, K:F.9, K:F.9, D:T.80, D:A.84, D:F.87, D:F.87, D:F.87, A:T.408, A:W.409, A:I.412, M:P.12, M:P.12, M:Q.15, M:L.19
- Water bridges: K:F.9
- Salt bridges: K:H.10
- Hydrogen bonds: A:T.408, M:K.4
PGV.38: 27 residues within 4Å:- Chain C: L.47, N.50, M.51, M.54, W.58, V.61, I.62, S.65, T.66, H.71, M.83, F.86, E.90, H.207, I.210, T.213, F.214, R.221, H.226, F.227, T.228, H.231, H.232, F.233, G.234
- Ligands: PGV.7, CDL.39
27 PLIP interactions:25 interactions with chain C, 2 interactions with chain F- Hydrophobic interactions: C:L.47, C:W.58, C:W.58, C:W.58, C:W.58, C:W.58, C:I.62, C:F.86, C:I.210, C:I.210, C:T.213, C:F.214, C:F.214, C:F.214
- Hydrogen bonds: C:S.65, C:R.221, C:F.233, C:G.234
- Water bridges: C:S.65, C:R.221, C:H.231, C:H.231, F:Q.12, F:E.17
- Salt bridges: C:R.221, C:R.221, C:H.231
PGV.43: 9 residues within 4Å:- Chain A: F.237, D.298
- Chain C: T.95, W.99, H.103, L.106, A.107
- Chain H: N.24
- Ligands: CHD.41
8 PLIP interactions:3 interactions with chain A, 1 interactions with chain H, 4 interactions with chain C- Hydrophobic interactions: A:F.237, C:T.95, C:W.99, C:W.99
- Water bridges: A:D.298, A:D.298, H:N.24
- Salt bridges: C:H.103
PGV.73: 3 residues within 4Å:- Chain G: A.1, A.3
- Ligands: CDL.72
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:A.1
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
TGL.9: 28 residues within 4Å:- Chain A: F.2, T.17, L.18, L.20, L.21, F.22, W.25, F.102, P.106, F.109, L.113, F.393, F.400, S.401, I.472
- Chain L: N.10, I.11, P.12, F.13, S.14, R.20, M.24, M.25, F.28, F.29, S.31
- Ligands: EDO.27, DMU.95
18 PLIP interactions:11 interactions with chain A, 7 interactions with chain L- Hydrophobic interactions: A:T.17, A:L.20, A:F.22, A:F.22, A:W.25, A:W.25, A:F.102, A:F.109, A:L.113, A:I.472, A:I.472, L:I.11, L:F.13, L:F.13, L:F.28, L:F.28, L:F.29, L:F.29
TGL.29: 16 residues within 4Å:- Chain A: F.346, V.350, T.354, Y.379, N.422, F.426, H.429, F.430, L.433
- Chain B: L.7, G.8, L.28, F.32, S.35, S.36
- Chain I: R.43
16 PLIP interactions:9 interactions with chain A, 1 interactions with chain I, 6 interactions with chain B- Hydrophobic interactions: A:F.346, A:F.346, A:V.350, A:T.354, A:N.422, A:F.426, A:F.426, A:H.429, A:F.430, B:L.7, B:F.32, B:F.32
- Salt bridges: I:R.43, B:H.24
- Water bridges: B:G.8, B:F.9
TGL.56: 21 residues within 4Å:- Chain A: W.334, M.339, L.342, G.343, F.414, A.415, F.418
- Chain B: L.39, I.42, T.47, K.49
- Chain D: R.73, S.74, T.75, E.77, W.78, V.81, I.89
- Chain I: R.16, H.20
- Ligands: DMU.61
14 PLIP interactions:6 interactions with chain A, 6 interactions with chain D, 2 interactions with chain B- Hydrophobic interactions: A:W.334, A:W.334, A:W.334, A:L.342, A:F.414, A:F.418, D:W.78, D:V.81, D:I.89, B:L.39, B:K.49
- Hydrogen bonds: D:T.75, D:E.77, D:W.78
- 56 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.10: 6 residues within 4Å:- Chain A: D.221, P.222, A.223
- Ligands: EDO.20, EDO.36, EDO.47
Ligand excluded by PLIPEDO.11: 9 residues within 4Å:- Chain A: R.5, N.11, K.13, D.14, W.81, P.499, P.500, Y.502
- Chain L: N.10
Ligand excluded by PLIPEDO.12: 9 residues within 4Å:- Chain A: Y.19, M.71, P.72, I.75, G.76, S.101, L.105, S.156, S.157
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: Q.52, A.137, H.138
- Chain B: W.104, G.201, S.202
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: Y.260, Y.261, V.394, H.395, P.398, W.494
- Chain M: I.1
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: V.485, D.486, L.487, T.488, T.489
Ligand excluded by PLIPEDO.16: 3 residues within 4Å:- Chain A: T.489
- Chain F: I.70, P.83
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain A: K.265, E.266
- Chain B: T.55
- Chain F: N.66, T.68, I.70, S.84
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain A: H.256, T.259, K.265, T.490, N.491
- Ligands: EDO.69
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain A: L.136, A.137
- Chain B: Q.103
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain A: P.131, D.221, P.222
- Ligands: EDO.10
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain A: G.269, Y.270, M.271, G.272
- Chain B: A.58, E.62
Ligand excluded by PLIPEDO.22: 7 residues within 4Å:- Chain A: M.390, H.413, M.417, A.464, V.465, M.468
- Ligands: HEA.1
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain A: E.119, A.120
- Ligands: EDO.84, EDO.92
Ligand excluded by PLIPEDO.24: 6 residues within 4Å:- Chain A: V.482, L.483, G.497, C.498
- Chain D: S.8, Y.11
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain A: P.174, T.509, Y.510, V.511
- Chain F: N.32, L.34, P.36, R.56
Ligand excluded by PLIPEDO.26: 8 residues within 4Å:- Chain A: Y.19, N.80, M.92, N.98, S.101, G.160, N.163, F.164
Ligand excluded by PLIPEDO.27: 2 residues within 4Å:- Chain A: F.2
- Ligands: TGL.9
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain B: W.104, Y.121, M.122, N.203, F.206
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain B: H.102, E.157, D.158
Ligand excluded by PLIPEDO.35: 7 residues within 4Å:- Chain A: Y.447
- Chain B: M.1, A.2, Q.10, L.136, P.166, Y.193
Ligand excluded by PLIPEDO.36: 4 residues within 4Å:- Chain B: E.157, P.176
- Ligands: EDO.10, EDO.47
Ligand excluded by PLIPEDO.37: 4 residues within 4Å:- Chain B: P.15, E.18, S.187
- Chain I: Y.51
Ligand excluded by PLIPEDO.47: 7 residues within 4Å:- Chain A: P.222
- Chain B: G.177
- Chain C: E.111
- Chain H: W.68
- Ligands: EDO.10, EDO.36, EDO.52
Ligand excluded by PLIPEDO.48: 10 residues within 4Å:- Chain C: W.146, S.150, D.155, H.158
- Chain F: A.1, S.2
- Chain G: A.13, R.14, R.17
- Ligands: EDO.70
Ligand excluded by PLIPEDO.49: 4 residues within 4Å:- Chain C: H.3, Q.4, H.70
- Chain F: L.16
Ligand excluded by PLIPEDO.50: 6 residues within 4Å:- Chain C: N.12, Q.68
- Chain J: L.18, V.20, K.23
- Ligands: EDO.80
Ligand excluded by PLIPEDO.51: 3 residues within 4Å:- Chain C: Q.68
- Chain F: G.15
- Chain J: Q.13
Ligand excluded by PLIPEDO.52: 5 residues within 4Å:- Chain B: G.177
- Chain C: E.111
- Chain H: W.68, W.72
- Ligands: EDO.47
Ligand excluded by PLIPEDO.57: 4 residues within 4Å:- Chain B: P.130
- Chain D: E.114, W.115, K.118
Ligand excluded by PLIPEDO.58: 2 residues within 4Å:- Chain D: Y.11
- Chain F: K.55
Ligand excluded by PLIPEDO.59: 7 residues within 4Å:- Chain D: Y.22, D.26
- Chain E: W.27, R.30, K.31, N.34
- Chain F: P.83
Ligand excluded by PLIPEDO.60: 7 residues within 4Å:- Chain A: T.488, L.495
- Chain D: Y.11, A.12, L.13, S.15
- Chain F: W.73
Ligand excluded by PLIPEDO.62: 3 residues within 4Å:- Chain E: Y.18, K.21, E.28
Ligand excluded by PLIPEDO.63: 3 residues within 4Å:- Chain E: R.53, R.56, R.57
Ligand excluded by PLIPEDO.64: 6 residues within 4Å:- Chain D: K.56
- Chain E: L.93, N.94, G.97, I.98, S.99
Ligand excluded by PLIPEDO.66: 6 residues within 4Å:- Chain A: Y.510
- Chain F: P.36, K.37, T.39, N.47, L.48
Ligand excluded by PLIPEDO.67: 3 residues within 4Å:- Chain C: H.231
- Chain F: D.9, E.17
Ligand excluded by PLIPEDO.68: 4 residues within 4Å:- Chain C: F.225
- Chain F: G.5, P.7
- Chain J: N.3
Ligand excluded by PLIPEDO.69: 7 residues within 4Å:- Chain A: T.489, T.490
- Chain F: S.67, T.68, V.69, W.71
- Ligands: EDO.18
Ligand excluded by PLIPEDO.70: 5 residues within 4Å:- Chain F: A.1
- Chain G: R.14, R.17
- Ligands: PEK.42, EDO.48
Ligand excluded by PLIPEDO.71: 4 residues within 4Å:- Chain F: F.72, Q.80, R.81, P.83
Ligand excluded by PLIPEDO.74: 4 residues within 4Å:- Chain C: F.35
- Chain G: K.58, P.59, S.61
Ligand excluded by PLIPEDO.75: 6 residues within 4Å:- Chain C: G.120
- Chain G: A.46, F.47, I.48, L.53, R.54
Ligand excluded by PLIPEDO.76: 3 residues within 4Å:- Chain G: A.46, F.47, Y.82
Ligand excluded by PLIPEDO.77: 5 residues within 4Å:- Chain A: D.227
- Chain B: G.177, R.178
- Chain H: N.24, T.26
Ligand excluded by PLIPEDO.80: 6 residues within 4Å:- Chain C: N.12, P.13
- Chain J: G.17, L.18, P.19
- Ligands: EDO.50
Ligand excluded by PLIPEDO.81: 3 residues within 4Å:- Chain J: Q.9, K.10, Q.13
Ligand excluded by PLIPEDO.82: 1 residues within 4Å:- Chain J: A.6
Ligand excluded by PLIPEDO.83: 4 residues within 4Å:- Chain A: F.8
- Chain J: H.21, L.22, Y.32
Ligand excluded by PLIPEDO.84: 8 residues within 4Å:- Chain A: V.118, E.119
- Chain J: A.53, S.54, F.55, P.56
- Chain L: K.46
- Ligands: EDO.23
Ligand excluded by PLIPEDO.91: 6 residues within 4Å:- Chain A: F.2
- Chain L: G.8, K.9, I.11, F.13, S.14
Ligand excluded by PLIPEDO.92: 6 residues within 4Å:- Chain A: E.119, A.120
- Chain L: Q.43, K.46, K.47
- Ligands: EDO.23
Ligand excluded by PLIPEDO.93: 3 residues within 4Å:- Chain L: S.31, F.38
- Ligands: DMU.95
Ligand excluded by PLIPEDO.97: 5 residues within 4Å:- Chain A: T.46, L.47
- Chain D: V.103
- Chain M: D.38, K.41
Ligand excluded by PLIPEDO.98: 2 residues within 4Å:- Chain M: H.36
- Ligands: DMU.96
Ligand excluded by PLIP- 15 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-functional Binders)(Non-covalent)
DMU.28: 3 residues within 4Å:- Ligands: DMU.85, DMU.86, DMU.88
No protein-ligand interaction detected (PLIP)DMU.45: 10 residues within 4Å:- Chain A: L.110
- Chain C: M.33, F.37
- Chain J: S.46, Y.48, C.49, L.50, W.52, A.53
- Ligands: DMU.53
7 PLIP interactions:4 interactions with chain J, 2 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: J:L.50, J:A.53, C:M.33, C:F.37, A:L.110
- Hydrogen bonds: J:Y.45, J:Y.45
DMU.53: 10 residues within 4Å:- Chain C: N.38, S.39, T.41, I.45
- Chain J: T.37, L.38, G.41, G.42, Y.45
- Ligands: DMU.45
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain J- Hydrophobic interactions: C:I.45, J:Y.45, J:Y.45
- Hydrogen bonds: C:N.38, C:S.39, C:S.39, J:Y.45
DMU.54: 7 residues within 4Å:- Chain C: W.34, M.40
- Chain G: W.62, G.63, F.69
- Ligands: PGV.7, PEK.44
7 PLIP interactions:5 interactions with chain G, 2 interactions with chain C- Hydrogen bonds: G:G.63
- Water bridges: G:W.62, G:D.64, G:F.69, G:F.69
- Hydrophobic interactions: C:W.34, C:W.34
DMU.55: 3 residues within 4Å:- Chain C: L.250, F.251
- Ligands: PEK.46
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.250, C:F.251
DMU.61: 3 residues within 4Å:- Chain D: S.74, W.78
- Ligands: TGL.56
9 PLIP interactions:1 interactions with chain K, 8 interactions with chain D- Water bridges: K:D.11, D:S.74, D:N.76, D:N.76, D:N.76
- Hydrophobic interactions: D:W.78, D:W.78, D:W.78
- Hydrogen bonds: D:S.74
DMU.79: 10 residues within 4Å:- Chain B: H.26, M.29, I.30, L.33, I.34, L.37, I.72, L.75
- Chain I: K.36
- Ligands: PSC.32
9 PLIP interactions:2 interactions with chain I, 7 interactions with chain B- Hydrogen bonds: I:K.36, I:E.41, B:H.26
- Hydrophobic interactions: B:I.30, B:L.33, B:I.34, B:L.37, B:L.75
- Salt bridges: B:H.26
DMU.85: 8 residues within 4Å:- Chain A: M.423
- Chain D: I.89
- Chain K: V.26, W.29, V.30
- Ligands: DMU.28, DMU.88, DMU.90
7 PLIP interactions:6 interactions with chain K, 1 interactions with chain D- Hydrophobic interactions: K:V.26, K:W.29, K:W.29, K:W.29, K:W.29, K:V.30, D:I.89
DMU.86: 7 residues within 4Å:- Chain K: A.33, T.34, Q.35, W.40
- Ligands: DMU.28, DMU.87, DMU.88
4 PLIP interactions:4 interactions with chain K- Hydrophobic interactions: K:W.40, K:W.40
- Hydrogen bonds: K:Q.35
- Water bridges: K:I.38
DMU.87: 9 residues within 4Å:- Chain D: L.94, L.95, I.97, H.101
- Chain K: Y.31, Q.35, I.36, G.37
- Ligands: DMU.86
9 PLIP interactions:6 interactions with chain D, 3 interactions with chain K- Hydrophobic interactions: D:L.94, D:L.95, D:I.97, D:H.101
- Water bridges: D:K.100, K:Q.35, K:G.37
- Salt bridges: D:H.101
- Hydrogen bonds: K:Y.31
DMU.88: 10 residues within 4Å:- Chain K: W.29, V.30, A.33, T.34, Q.35, W.40
- Ligands: DMU.28, DMU.85, DMU.86, DMU.90
4 PLIP interactions:4 interactions with chain K- Hydrophobic interactions: K:W.29, K:V.30, K:A.33, K:W.40
DMU.89: 7 residues within 4Å:- Chain K: N.15, A.19, S.20, T.23, F.24, A.27
- Ligands: DMU.90
8 PLIP interactions:8 interactions with chain K- Hydrophobic interactions:
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x PER: PEROXIDE ION(Non-covalent)
- 5 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
- 56 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 15 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-functional Binders)(Non-covalent)